PRESCIENT HEALTHCARE GROUP LIMITED - Profile & Financials

Accounts Submitted 2 Jul 2025

Confirmation Statement Submitted 24 Jun 2025

Net assets £31.62M £2.16M 2024 year on year

Total assets £50.99M £9.44M 2024 year on year

Total Liabilities £19.37M £7.28M 2024 year on year

Charges 8

2 outstanding 6 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Cp House 97-107 Uxbridge Road Ealing London W5 5TL

Office (Jersey City, New Jersey, US)

15 Exchange Place, Suite 730, Jersey City, New Jersey, 07302, US

Telephone

+14152308460

bdoran@prescienthg.com

Website

prescienthg.com

Credit Report

Discover PRESCIENT HEALTHCARE GROUP LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£3.74M

Decreased by £1.76M (-32%)

Net Assets

£31.62M

Increased by £2.16M (+7%)

Total Liabilities

£19.37M

Increased by £7.28M (+60%)

Turnover

£38.10M

Decreased by £3.09M (-7%)

Employees

319

Decreased by 22 (-6%)

Debt Ratio

38%

Increased by 9 (+31%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£12.6m raised

Show:

Investors (2)

Investor Name	Investor Since	Participating Rounds
Baird Capital	Jul 2017	Series B, Early-Stage
Bridgepoint Development Capital	Jan 2021	Series B

Share Capital

Share allotments and capital structure

5 Allotments 12,500 Shares £274.34m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
30 Sept 2014	A ORDINARY	4,000	£79.36m	£20k
17 Sept 2014	A ORDINARY	4,000	£160.00m	£40k
11 Sept 2014	A ORDINARY	2,500	£26.50m	£11k
31 Dec 2012	ORDINARY A	1,000	£4.24m	£4k
14 Dec 2012	ORDINARY A	1,000	£4.24m	£4k

Officers

3 active 15 resigned

Show resigned officers

						Status
Jason Mckenna	Director	American	United States	49	13 Jan 2025	Active
Nicholas Huw Edwards	Director	British	England	64	14 Jun 2024	Active
Rachael Anne Farmer	Director	British	United Kingdom	48	28 Feb 2025	Active

Shareholders

Shareholders (2)


Prescient Healthcare Group (holdings) Limited	88.2%	154,351	A Ordinary	9 Dec 2016
Prescient Healthcare Group (holdings) Limited	11.8%	20,700	Preferred Ordinary	9 Dec 2016

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Prescient Healthcare Group (holdings) Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent

See All Controllers

Group Structure

PRESCIENT HEALTHCARE GROUP (HOLDINGS) LIMITED united kingdom shares 75 to 100 percent

GRINDCO 614 LIMITED united kingdom shares 75 to 100 percent

VISION BIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

VISION MIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

VISION TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROJECT VISION BIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROJECT VISION MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROJECT VISION MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROJECT VISION TOPCO LIMITED united kingdom significant influence or control

BRIDGEPOINT ADVISERS II LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BDC III GP LLP united kingdom right to share surplus assets 25 to 50 percent limited liability partnership

BDC III GP 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BDC III GP 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BRIDGEPOINT ADVISERS HOLDINGS united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BRIDGEPOINT ADVISERS GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BRIDGEPOINT GROUP HOLDINGS LIMITED united kingdom significant influence or control

BRIDGEPOINT ADVISERS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BRIDGEPOINT OP GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BRIDGEPOINT GROUP PLC united kingdom

PRESCIENT HEALTHCARE GROUP LIMITED Current Company

CONSULT GB LIMITED united kingdom shares 75 to 100 percent

PRESCIENT HEALTHCARE GROUP (UK) LIMITED united kingdom shares 75 to 100 percent

Charges

2 outstanding 6 satisfied

Documents

Company Filings

Date	Category	Description	Document
8 Dec 2025	Persons With Significant Control	Project Vision Bidco Limited notified as a person with significant control	View(2 pages)
8 Dec 2025	Persons With Significant Control	Cessation of Prescient Healthcare Group (Holdings) Limited as a person with significant control on 2025-11-28	View(1 page)
28 Nov 2025	Capital	Statement by Directors	View(1 page)
28 Nov 2025	Insolvency	Solvency Statement dated 28/11/25	View(1 page)
28 Nov 2025	Capital	Capital Statement Capital Company With Date Currency Figure	View(3 pages)